
Partnerships
Engaging in a value-driven partnership with Sciensus means you’ll be working with more than 1,600 professionals who genuinely understand your challenges, your ambitions and how to achieve them.
Why choose Sciensus
We are a European life sciences company specialising in market-leading patient access, engagement and insight solutions. With a presence across Europe, we sit proudly at the intersection of patients and their medicine, specifically those with cancer, chronic conditions, rare and speciality disease therapies.
Biopharma
Powered by 70 million patient interactions, we support pharma companies across the entire drug lifecycle, from pre-approval programs and access to influential prescribers to ongoing real-world data collection and insight-led patient engagement.
NHS
We have been working with the NHS for 30 years, and now partner with almost 400 NHS organisations across the UK. The end-to-end service we provide helps thousands of patients with both simple and complex health conditions manage their treatments and live their lives to the fullest.
Healthcare professionals
With coverage across the UK, our expert team delivers a high level of patient-centric care across more than 70 therapy areas, providing timely clinical assessments after every visit.
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.

Thought Leadership
Powering rare disease access with real-world evidence

Blogs
Bringing NHS voices together to drive Sciensus’ NHS improvement roadmap
When Sciensus designed its dedicated NHS digital platform, Sciensus Connect, it brought together voices from across the health service to…

Events
PCMG 2025
Your partner to unlock access to European patients With over 30 years of experience, 240,000 patients treated annually across 60…